Cargando…

Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism

Calorie restriction (CR) can prolong the human lifespan, but enforcing long-term CR is difficult. Therefore, a compound that reproduces the effect of CR without CR is needed. In this review, we summarize the current knowledge on compounds with CR mimetic (CRM) effects. More than 10 compounds have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Shintani, Hideya, Shintani, Tomoya, Ashida, Hisashi, Sato, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316630/
https://www.ncbi.nlm.nih.gov/pubmed/30469486
http://dx.doi.org/10.3390/nu10121821
_version_ 1783384575157731328
author Shintani, Hideya
Shintani, Tomoya
Ashida, Hisashi
Sato, Masashi
author_facet Shintani, Hideya
Shintani, Tomoya
Ashida, Hisashi
Sato, Masashi
author_sort Shintani, Hideya
collection PubMed
description Calorie restriction (CR) can prolong the human lifespan, but enforcing long-term CR is difficult. Therefore, a compound that reproduces the effect of CR without CR is needed. In this review, we summarize the current knowledge on compounds with CR mimetic (CRM) effects. More than 10 compounds have been listed as CRMs, some of which are conventionally categorized as upstream-type CRMs showing glycolytic inhibition, while the others are categorized as downstream-type CRMs that regulate or genetically modulate intracellular signaling proteins. Among these, we focus on upstream-type CRMs and propose their classification as compounds with energy metabolism inhibition effects, particularly glucose metabolism modulation effects. The upstream-type CRMs reviewed include chitosan, acarbose, sodium-glucose cotransporter 2 inhibitors, and hexose analogs such as 2-deoxy-d-glucose, d-glucosamine, and d-allulose, which show antiaging and longevity effects. Finally, we discuss the molecular definition of upstream-type CRMs.
format Online
Article
Text
id pubmed-6316630
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63166302019-01-08 Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism Shintani, Hideya Shintani, Tomoya Ashida, Hisashi Sato, Masashi Nutrients Review Calorie restriction (CR) can prolong the human lifespan, but enforcing long-term CR is difficult. Therefore, a compound that reproduces the effect of CR without CR is needed. In this review, we summarize the current knowledge on compounds with CR mimetic (CRM) effects. More than 10 compounds have been listed as CRMs, some of which are conventionally categorized as upstream-type CRMs showing glycolytic inhibition, while the others are categorized as downstream-type CRMs that regulate or genetically modulate intracellular signaling proteins. Among these, we focus on upstream-type CRMs and propose their classification as compounds with energy metabolism inhibition effects, particularly glucose metabolism modulation effects. The upstream-type CRMs reviewed include chitosan, acarbose, sodium-glucose cotransporter 2 inhibitors, and hexose analogs such as 2-deoxy-d-glucose, d-glucosamine, and d-allulose, which show antiaging and longevity effects. Finally, we discuss the molecular definition of upstream-type CRMs. MDPI 2018-11-22 /pmc/articles/PMC6316630/ /pubmed/30469486 http://dx.doi.org/10.3390/nu10121821 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Shintani, Hideya
Shintani, Tomoya
Ashida, Hisashi
Sato, Masashi
Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
title Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
title_full Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
title_fullStr Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
title_full_unstemmed Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
title_short Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
title_sort calorie restriction mimetics: upstream-type compounds for modulating glucose metabolism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316630/
https://www.ncbi.nlm.nih.gov/pubmed/30469486
http://dx.doi.org/10.3390/nu10121821
work_keys_str_mv AT shintanihideya calorierestrictionmimeticsupstreamtypecompoundsformodulatingglucosemetabolism
AT shintanitomoya calorierestrictionmimeticsupstreamtypecompoundsformodulatingglucosemetabolism
AT ashidahisashi calorierestrictionmimeticsupstreamtypecompoundsformodulatingglucosemetabolism
AT satomasashi calorierestrictionmimeticsupstreamtypecompoundsformodulatingglucosemetabolism